9HTS | pdb_00009hts

Human KHNYN KH domain


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.20 Å
  • R-Value Free: 
    0.259 (Depositor), 0.257 (DCC) 
  • R-Value Work: 
    0.196 (Depositor), 0.202 (DCC) 

Starting Model: in silico
View more details

wwPDB Validation   3D Report Full Report


This is version 1.1 of the entry. See complete history


Literature

Structural and functional characterization of the extended-diKH domain from the antiviral endoribonuclease KHNYN.

Youle, R.L.Lista, M.J.Bouton, C.Kunzelmann, S.Wilson, H.Cottee, M.A.Purkiss, A.G.Morris, E.R.Neil, S.J.D.Taylor, I.A.Swanson, C.M.

(2025) J Biological Chem 301: 108336-108336

  • DOI: https://doi.org/10.1016/j.jbc.2025.108336
  • Primary Citation of Related Structures:  
    9HTS

  • PubMed Abstract: 

    Zinc finger antiviral protein (ZAP) binds CpG dinucleotides in viral RNA and targets them for decay. ZAP interacts with several cofactors to form the ZAP antiviral system, including KHNYN, a multidomain endoribonuclease required for ZAP-mediated RNA decay. However, it is unclear how the individual domains in KHNYN contribute to its activity. Here, we demonstrate that the KHNYN amino-terminal extended-diKH (ex-diKH) domain is required for antiviral activity and present its crystal structure. The structure belongs to a rare group of KH-containing domains, characterized by a noncanonical arrangement between two type 1 KH modules, with an additional helical bundle. N4BP1 is a KHNYN paralog with an ex-diKH domain that functionally complements the KHNYN ex-diKH domain. Interestingly, the ex-diKH domain structure is present in N4BP1-like proteins in lancelets, which are basal chordates, indicating that it is evolutionarily ancient. While many KH domains demonstrate RNA binding activity, biolayer interferometry and electrophoretic mobility shift assays indicate that the KHNYN ex-diKH domain does not bind RNA. Furthermore, residues required for canonical KH domains to bind RNA are not required for KHNYN antiviral activity. By contrast, an inter-KH domain cleft in KHNYN is a potential protein-protein interaction site, and mutations that eliminate arginine salt bridges at the edge of this cleft decrease KHNYN antiviral activity. This suggests that this domain could be a binding site for an unknown KHNYN cofactor.


  • Organizational Affiliation
    • Department of Infectious Diseases, King's College London, London, United Kingdom; Macromolecular Structure Laboratory, The Francis Crick Institute, London, United Kingdom.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Protein KHNYN
A, B
194Homo sapiensMutation(s): 0 
Gene Names: KHNYNKIAA0323
UniProt & NIH Common Fund Data Resources
Find proteins for O15037 (Homo sapiens)
Explore O15037 
Go to UniProtKB:  O15037
PHAROS:  O15037
GTEx:  ENSG00000100441 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupO15037
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.20 Å
  • R-Value Free:  0.259 (Depositor), 0.257 (DCC) 
  • R-Value Work:  0.196 (Depositor), 0.202 (DCC) 
Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 28.833α = 90
b = 121.797β = 108.545
c = 44.547γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
XDSdata reduction
STARANISOdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Wellcome TrustUnited KingdomCC2029
Medical Research Council (MRC, United Kingdom)United KingdomCC2029
Cancer Research UKUnited KingdomCC2029

Revision History  (Full details and data files)

  • Version 1.0: 2025-02-26
    Type: Initial release
  • Version 1.1: 2025-08-06
    Changes: Database references, Structure summary